Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
Cancer became recently the leading cause of death in industrialized countries. Even though standard treatments achieve significant effects in growth inhibition and tumor elimination, they cause severe side effects as most of the applied drugs exhibit only minor selectivity for the malignant tissue....
Main Authors: | Paul Hoppenz, Sylvia Els-Heindl, Annette G. Beck-Sickinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fchem.2020.00571/full |
Similar Items
-
Cyclic Derivatives of the Chemerin C-Terminus as Metabolically Stable Agonists at the Chemokine-like Receptor 1 for Cancer Treatment
by: Tobias F. Fischer, et al.
Published: (2021-07-01) -
Automated solid-phase peptide synthesis to obtain therapeutic peptides
by: Veronika Mäde, et al.
Published: (2014-05-01) -
Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy
by: Tohru Yoneyama, et al.
Published: (2021-01-01) -
Recent Advances in the Synthesis of High Boron-Loaded Nucleic Acids for BNCT
by: Darya Sergeevna Novopashina, et al.
Published: (2021-03-01) -
Peptide Conjugates as Useful Molecular Tools
by: Ślósarczyk, Adam T.
Published: (2011)